可摄入式感测器市场－全球产业规模、份额、趋势、机会及预测（按组件、感测器、垂直产业、地区和竞争格局划分，2021-2031年）

全球口服型感测器市场预计将从 2025 年的 24.9 亿美元成长到 2031 年的 50.7 亿美元，复合年增长率为 12.58%。

这些小型电子设备表面涂覆有生物相容性材料，可透过口服方式监测药物依从性、胃肠道成像或监测内部生理指标。该市场的成长主要受慢性胃肠道疾病发病率上升以及对非侵入性诊断方法（作为传统内视镜检查的替代方案）需求成长的驱动。此外，全球向数位化医疗解决方案和远端患者监护的转变也持续推动这些先进技术的应用。

然而，该行业面临诸多障碍，复杂的采购流程和严格的监管程序会阻碍商业性准入。 Ⅱ类或III类医疗设备的核准需要大量的临床检验，而这往往与过时的报销体系相衝突。英国医疗技术产业协会的报告凸显了这些挑战，报告显示，到2024年，监管的不确定性和不切实际的竞标条件导致50%的受访医疗技术公司推迟了新技术的引进。这些主要地区的障碍凸显了将快速的技术进步与现有医疗保健框架相协调的困难。

市场驱动因素

慢性心血管疾病和胃肠道疾病发病率的上升正在从根本上改变全球口服型感测器市场，对比传统方法更精准的诊断工具的需求日益增长。随着心律不整和功能性肠道疾病盛行率的增加，医疗保健机构正转向使用口服型胶囊来获取体内连续、即时的生理数据。根据Atmo Biosciences公司于2024年4月发布的关于一项关键性临床试验的新闻稿，全球约有40%的人口患有消化器官系统疾病，这使得全球迫切需要有效、非侵入性的诊断方法。不断增长的患者群体迫使製造商扩大其设备的临床应用范围和目标年龄范围。例如，Anx Robotica公司于2024年1月获得FDA核准，用于两岁及以上儿童的小肠视讯胶囊内视镜系统。

另一个推动因素是远端医疗和远端患者监护解决方案需求的激增，这加速了口服型感测器在分散式医疗模式中的应用。随着医疗系统寻求在家中治疗慢性病并减少患者再次入院，感测胶囊和数位药丸提供了一种无需医疗专业人员直接参与即可追踪体内生命体征和药物依从性的检验方法。这种居家管理趋势得到了快速普及的支持；HealthArc在2024年10月报告称，到2024年，美国接受远端患者监护的患者人数将增长至3000万。可摄入式感测器正成为此基础设施的关键组成部分，使医生能够远端接收可操作的依从性数据，从而实现处方与患者依从性之间的闭环。

市场挑战

严格的监管流程和复杂的采购程序给全球口服型感测器市场带来了巨大挑战。这些繁琐的官僚障碍显着延长了产品核可时间，并要求製造商对II类和III类医疗设备进行耗时耗资的临床检验。因此，创新口服型技术的上市往往被推迟，限制了商业性应用，并减缓了医疗机构的采纳速度。这种情况造成了很高的进入门槛，尤其对于缺乏资源来应对漫长上市前阶段的中小型企业而言，最终会抑制产业竞争，并阻碍技术进步。

这些监管瓶颈带来的负面影响因合规成本的不断攀升而加剧，直接侵蚀了投资能力和利润率。根据欧洲医疗技术协会（MedTech Europe）2024年的数据，在更新后的法规结构下，医疗设备的认证和维护成本将比旧标准增加高达100%。这种财务负担的急剧增加迫使企业将资金从研发中转移，直接阻碍了产业的创新能力。因此，非侵入性诊断工具的供应无法满足日益增长的全球需求，限制了口腔感测器产业的扩充性和收入成长。

市场趋势

用于微生物组分析的气体感测胶囊的兴起，标誌着胃肠道内成像技术从结构成像转变为功能代谢谱分析的重要转变。与依赖视觉确认异常的传统内视镜不同，这些口服感测器能够识别特定的气体生物标记物，例如甲烷和氢气，从而提供有关发酵过程和肠道蠕动的即时数据。这项功能对于诊断小肠细菌过度生长（SIBO）等功能性疾病至关重要，因为这些疾病通常缺乏视觉指标。为了展示这项技术的临床应用进展，Atmo Biosciences公司于2024年4月宣布，已成功完成一项涉及200多名受试者的关键性临床试验，证明了该胶囊在评估肠道转运时间（局部和整体性）方面的有效性。

同时，融合机器学习和人工智慧的预测分析技术正透过自动化数据解读，彻底革新口腔感测器的诊断能力。製造商正将先进的深度学习演算法整合到其感测器平台中，以快速分析海量的生理和影像数据，显着缩短胃肠病学家解读影像所需的时间，同时提高诊断准确率。这项技术整合解决了检测细微病变时人为误差这一重大挑战。为了支持这一趋势，AnX Robotica 于 2024 年 1 月宣布，其新近获得 FDA 批准的小肠胶囊内视镜人工智慧辅助解读工具在临床检验中，对个别患者分析的灵敏度达到了 99.88%。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球可摄入式感测器市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按组件划分（感测器、穿戴式贴片/资料记录器、软体）
  • 透过感测器（温度感测器、压力感测器、pH感测器、影像感测器）
  • 按行业（医疗、运动和健身）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美可摄入式感测器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲可摄入式感测器市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区可摄入式感测器市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲可摄入式感测器市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲可摄入式感测器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球可摄入式感测器市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• RF Co. Ltd
• CapsoVision Inc.
• Medtronic Inc
• Olympus Corporation
• Given Imaging Ltd.
• Medimetrics
• Microchips Biotech, Inc.
• Check-Cap Ltd
• IntroMedic Co., Ltd.
• Sensirion AG

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Ingestible Sensor Market is projected to expand from USD 2.49 Billion in 2025 to USD 5.07 Billion by 2031, registering a CAGR of 12.58%. These devices, which are miniaturized electronics encased in biocompatible materials, are swallowed to track medication adherence, image the gastrointestinal tract, or monitor internal physiological metrics. The market is primarily propelled by the growing burden of chronic gastrointestinal conditions and a rising preference for non-invasive diagnostic options over conventional endoscopy. Additionally, the worldwide transition toward digitized healthcare solutions and remote patient monitoring continues to bolster the uptake of these advanced technologies.

However, the sector encounters considerable obstacles due to complex procurement procedures and strict regulatory pathways that can impede commercial access. Securing approval for these Class II or Class III medical devices demands extensive clinical validation, which frequently conflicts with antiquated reimbursement structures. Highlighting these difficulties, the Association of British HealthTech Industries reported in 2024 that regulatory ambiguity and unfeasible tender conditions caused 50% of surveyed health technology firms to postpone the launch of new innovations. These barriers in major regions underscore the challenge of harmonizing rapid technological progress with established healthcare frameworks.

Market Driver

The rising incidence of chronic cardiovascular and gastrointestinal diseases is fundamentally transforming the Global Ingestible Sensor Market, creating a strong demand for diagnostic tools that provide higher precision than traditional methods. As the prevalence of cardiac irregularities and functional gut disorders increases, healthcare providers are turning to ingestible capsules to obtain continuous, real-time physiological data from inside the body. According to an April 2024 media release by Atmo Biosciences regarding a pivotal clinical study, nearly 40% of the global population suffers from gastrointestinal issues, highlighting the urgent worldwide need for effective, non-invasive diagnostics. This growing patient volume is compelling manufacturers to broaden the clinical application and reach of their devices, as seen in January 2024 when AnX Robotica announced FDA clearance to use its Small Bowel Video Capsule Endoscopy system in patients as young as two years old.

A parallel catalyst is the surging demand for telehealth and remote patient monitoring solutions, which accelerates the incorporation of ingestible sensors into decentralized care models. As healthcare systems aim to treat chronic illnesses at home and reduce hospital readmissions, sensing capsules and digital pills offer a verifiable method to track internal vitals and medication adherence without direct clinician involvement. This trend toward home-based management is supported by rapid adoption rates; HealthArc reported in October 2024 that the number of patients in the United States using remote patient monitoring increased to 30 million in 2024. Ingestible sensors are becoming a crucial element of this infrastructure, allowing physicians to receive actionable compliance data remotely and closing the loop between prescription and patient adherence.

Market Challenge

Stringent regulatory pathways and intricate procurement processes present a major challenge for the Global Ingestible Sensor Market. These bureaucratic hurdles significantly prolong the time needed for product approval, requiring manufacturers to navigate expensive and lengthy clinical validation steps for Class II and Class III devices. Consequently, the launch of innovative ingestible technologies is often delayed, restricting their commercial availability and slowing their adoption by healthcare providers. This landscape establishes high entry barriers, especially for smaller firms lacking the resources to endure extended pre-market phases, which ultimately stifles competition and decelerates technological advancement within the industry.

The negative impact of these regulatory bottlenecks is intensified by rising compliance costs, which directly deplete investment capabilities and profit margins. Data from MedTech Europe in 2024 indicates that certification and maintenance expenses for medical devices under updated regulatory frameworks have jumped by up to 100% compared to previous standards. This sharp increase in financial burden forces companies to divert capital away from research and development, directly impeding the industry's capacity to innovate. As a result, the market struggles to match the supply of non-invasive diagnostic tools with growing global demand, limiting the scalability and revenue growth of the ingestible sensor sector.

Market Trends

The rise of gas-sensing capsules for microbiome analysis represents a significant evolution from structural imaging to functional metabolic profiling within the gastrointestinal tract. Unlike traditional endoscopy, which depends on visual confirmation of abnormalities, these ingestible sensors identify specific gaseous biomarkers like methane and hydrogen to provide real-time data on fermentation processes and gut motility. This functionality is essential for diagnosing functional disorders such as Small Intestinal Bacterial Overgrowth (SIBO), where visual indicators are often missing. Demonstrating the clinical advancement of this technology, Atmo Biosciences announced in April 2024 that it successfully completed a pivotal trial with over 200 subjects to validate the capsule's efficacy in assessing regional and whole gut transit time.

At the same time, the integration of machine learning and artificial intelligence for predictive analytics is revolutionizing the diagnostic capabilities of ingestible sensors by automating data interpretation. Manufacturers are embedding sophisticated deep learning algorithms into sensor platforms to rapidly analyze immense volumes of physiological and video data, drastically reducing the reading time for gastroenterologists while improving diagnostic precision. This technological convergence resolves the critical issue of human error in detecting subtle pathologies. Validating this trend, AnX Robotica announced in January 2024 that its newly FDA-cleared AI-assisted reading tool for small bowel capsule endoscopy achieved a 99.88% sensitivity in per-patient analysis during clinical validation.

Key Market Players

• RF Co. Ltd
• CapsoVision Inc.
• Medtronic Inc
• Olympus Corporation
• Given Imaging Ltd.
• Medimetrics
• Microchips Biotech, Inc.
• Check-Cap Ltd
• IntroMedic Co., Ltd.
• Sensirion AG

Report Scope

In this report, the Global Ingestible Sensor Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ingestible Sensor Market, By Component

• Sensor
• Wearable Patch/ Data Recorder
• Software

Ingestible Sensor Market, By Sensor

• Temperature Sensor
• Pressure Sensor
• pH Sensor
• Image Sensor

Ingestible Sensor Market, By Vertical

• Medical
• Sports & Fitness

Ingestible Sensor Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ingestible Sensor Market.

Available Customizations:

Global Ingestible Sensor Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ingestible Sensor Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Sensor, Wearable Patch/ Data Recorder, Software)
  • 5.2.2. By Sensor (Temperature Sensor, Pressure Sensor, pH Sensor, Image Sensor)
  • 5.2.3. By Vertical (Medical, Sports & Fitness)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Ingestible Sensor Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Sensor
  • 6.2.3. By Vertical
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ingestible Sensor Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Sensor
      • 6.3.1.2.3. By Vertical
  • 6.3.2. Canada Ingestible Sensor Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Sensor
      • 6.3.2.2.3. By Vertical
  • 6.3.3. Mexico Ingestible Sensor Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Sensor
      • 6.3.3.2.3. By Vertical

7. Europe Ingestible Sensor Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Sensor
  • 7.2.3. By Vertical
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Ingestible Sensor Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Sensor
      • 7.3.1.2.3. By Vertical
  • 7.3.2. France Ingestible Sensor Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Sensor
      • 7.3.2.2.3. By Vertical
  • 7.3.3. United Kingdom Ingestible Sensor Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Sensor
      • 7.3.3.2.3. By Vertical
  • 7.3.4. Italy Ingestible Sensor Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Sensor
      • 7.3.4.2.3. By Vertical
  • 7.3.5. Spain Ingestible Sensor Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Sensor
      • 7.3.5.2.3. By Vertical

8. Asia Pacific Ingestible Sensor Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Sensor
  • 8.2.3. By Vertical
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Ingestible Sensor Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Sensor
      • 8.3.1.2.3. By Vertical
  • 8.3.2. India Ingestible Sensor Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Sensor
      • 8.3.2.2.3. By Vertical
  • 8.3.3. Japan Ingestible Sensor Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Sensor
      • 8.3.3.2.3. By Vertical
  • 8.3.4. South Korea Ingestible Sensor Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Sensor
      • 8.3.4.2.3. By Vertical
  • 8.3.5. Australia Ingestible Sensor Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Sensor
      • 8.3.5.2.3. By Vertical

9. Middle East & Africa Ingestible Sensor Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Sensor
  • 9.2.3. By Vertical
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Ingestible Sensor Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Sensor
      • 9.3.1.2.3. By Vertical
  • 9.3.2. UAE Ingestible Sensor Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Sensor
      • 9.3.2.2.3. By Vertical
  • 9.3.3. South Africa Ingestible Sensor Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Sensor
      • 9.3.3.2.3. By Vertical

10. South America Ingestible Sensor Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Sensor
  • 10.2.3. By Vertical
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Ingestible Sensor Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Sensor
      • 10.3.1.2.3. By Vertical
  • 10.3.2. Colombia Ingestible Sensor Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Sensor
      • 10.3.2.2.3. By Vertical
  • 10.3.3. Argentina Ingestible Sensor Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Sensor
      • 10.3.3.2.3. By Vertical

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Ingestible Sensor Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. RF Co. Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. CapsoVision Inc.
• 15.3. Medtronic Inc
• 15.4. Olympus Corporation
• 15.5. Given Imaging Ltd.
• 15.6. Medimetrics
• 15.7. Microchips Biotech, Inc.
• 15.8. Check-Cap Ltd
• 15.9. IntroMedic Co., Ltd.
• 15.10. Sensirion AG

16. Strategic Recommendations

17. About Us & Disclaimer